GreenLight Biosciences Holdings, PBC Warrant
GRNAW
GRNAW was delisted on the 21st of July, 2023.
22 hedge funds and large institutions have $6.26M invested in GreenLight Biosciences Holdings, PBC Warrant in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
72% more capital invested
Capital invested by funds: $3.65M → $6.26M (+$2.62M)
29% more funds holding
Funds holding: 17 → 22 (+5)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$285K |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$144K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$57K |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$25.4K |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$22.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$62.9K |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$58.9K |
| 3 |
CAC
Cowen and Company
New York
|
-$40K |
| 4 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$32.9K |
| 5 |
Goldman Sachs
New York
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Goldman Sachs
New York
| – | -$23K | -26,883 | Closed |
|
GRNAW Hedge Fund Activity: Q2 2021 in Review
22 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q2 2021, worth a combined $6.26M — up 72% from $3.65M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GRNAW positions and 3 closed out — a net gain of 5 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $285K. The largest seller was Polar Asset Management Partners, cutting an estimated $62.9K.
- 22 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q2 2021, up from 17 in Q1 2021.
- Funds reported $6.26M of GreenLight Biosciences Holdings, PBC Warrant stock for Q2 2021, up 72% quarter-over-quarter.
- 8 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q2 2021 and 3 closed out, a net change of +5 holders.
- The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q2 2021 was Aristeia Capital, an estimated $285K added.
- The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q2 2021 was Polar Asset Management Partners, an estimated $62.9K sold.
Based on aggregated 13F filings for Q2 2021.